Determinants of cervical high-risk human papillomavirus positivity among Rwandan women living with human immunodeficiency virus
Our findings highlight the role of CD4 counts, as a measure of HIV control and immunity, in controlling hrHPV infection, which could potentially impact cervical cancer control among this high-risk population. Raising awareness on various associated factors coupled with integrating HPV and cervical cancer awareness in HIV care could help control this double burden of disease.
Authors
- Tiffany Hébert (ORCID: https://orcid.org/0000-0002-3408-6020)
- Benjamin Muhoza
- Adebola Adedimeji (ORCID: https://orcid.org/0000-0002-8012-9124)
- Anthère Murangwa
- Gallican Kubwimana
- Léon Mutesa (ORCID: https://orcid.org/0000-0002-5308-3706)
- Maria Demarco (ORCID: https://orcid.org/0000-0001-8501-7984)
- Philip E. Castle (ORCID: https://orcid.org/0000-0002-6408-5985)
- Kristen Hansen (ORCID: https://orcid.org/0000-0001-7399-7911)
- Marcel Yotebieng (ORCID: https://orcid.org/0000-0003-2110-2631)
- Julia C. Gage (ORCID: https://orcid.org/0000-0001-5259-6385)
- Theogene Rurangwa
- Laetitia Nyirazinyoye
- Thierry Zawadi
- Kathryn Anastos
- Gad Murenzi (ORCID: https://orcid.org/0000-0002-5513-5522)
- Faustin Kanyabwisha (ORCID: https://orcid.org/0000-0002-1774-7739)
- Jean Paul Mivumbi
Institutions
- National Institutes of Health (US)
- Albert Einstein College of Medicine (US)
- University of Rwanda (RW)
- Rwanda Military Hospital (RW)
- National Cancer Institute (US)
- Wake Forest University (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1371/journal.pone.0333077
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00